Patterns of Prescription Opioid Abuse and Comorbidity in an Aging Treatment Population by Cicero, Theodore J. et al.
Nova Southeastern University 
NSUWorks 
CAHSS Faculty Articles Faculty Scholarship 
1-1-2012 
Patterns of Prescription Opioid Abuse and Comorbidity in an 
Aging Treatment Population 
Theodore J. Cicero 
Washington University in St. Louis, cicerot@wustl.edu 
Hilary L. Surratt 
Nova Southeastern University, surratt@nova.edu 
Steven P. Kurtz 
Nova Southeastern University, steven.kurtz@nova.edu 
Matthew Ellis 
Washington University School of Medicine in St. Louis, ellism@wustl.edu 
James A Inciardi 
University of Delaware 
Follow this and additional works at: https://nsuworks.nova.edu/shss_facarticles 
 Part of the Arts and Humanities Commons, and the Social and Behavioral Sciences Commons 
NSUWorks Citation 
Cicero, T. J., Surratt, H. L., Kurtz, S. P., Ellis, M., & Inciardi, J. (2012). Patterns of Prescription Opioid Abuse 
and Comorbidity in an Aging Treatment Population. Journal of Substance Abuse Treatment, 42 (1), 87-94. 
https://doi.org/10.1016/j.jsat.2011.07.003 
This Article is brought to you for free and open access by the Faculty Scholarship at NSUWorks. It has been 
accepted for inclusion in CAHSS Faculty Articles by an authorized administrator of NSUWorks. For more 
information, please contact nsuworks@nova.edu. 
Brief article
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Abstract
Very little is known about the impact of age and gender on drug abuse treatment needs. To examine this, we recruited 2,573 opioid-dependent
patients, aged from 18 to 75 years, entering treatment across the country from 2008 to 2010 to complete a self-administered survey examining
drug use histories and the extent of comorbid psychiatric and physical disorders. Moderate to very severe pain and psychiatric disorders,
including polysubstance abuse, were present in a significant fraction of 18- to 24-year-olds, but their severity grew exponentially as a function of
age: 75% of those older than 45 years had debilitating pain and psychiatric problems. Women had more pain than men and much worse
psychiatric issues in all age groups. Our results indicate that a “one-size-fits-all” approach to prevention, intervention, and treatment of opioid
abuse that ignores the shifting needs of opioid-abusing men and women as they age is destined to fail. © 2012 Elsevier Inc. All rights reserved.
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1. Introduction
It is clear from many nationally based surveys and other
studies that the “recreational” use of opioids for nonther-
apeutic purposes, that is, to get high, has shown major
increases in the past 15 years or so, particularly in adolescents
and young adults (Cai, Crane, Poneleit, & Paulozzi,
2010; Boyles, 2009; McCabe, Cranford, & West, 2008;
Manchikanti, Fellows, Ailinani, & Pampati, 2010; Rogers &
Copley, 2009; Skurtveit, Furu, Selmer, Handal, & Tverdal,
2010; Schulden, Thomas, & Compton, 2009). Although there
is little systematic data available, it seems certain that only a
small fraction of these first-time users will ultimately develop
problematic use or abuse of prescription opioids. What
distinguishes at-risk individuals from true recreational users
who can use drugs occasionallywith few negative effects is not
fully understood. However, recent data indicate that thosemost
likely to progress from misuse to abuse have significant levels
of pain (often undertreated) and other medical and psychiatric
comorbid conditions, including nicotine and alcohol abuse
(Cicero et al., 2009;McCabe et al., 2008; Skurtveit et al., 2010;
Sullivan, Edlund, Steffick,&Unützer, 2005; Sullivan, Edlund,
Zhang, Unützer, & Wells, 2006). Given the extent of
preexisting comorbidity and the ensuing disabilities inflicted
by years of substance abuse, it seems logical to predict that, as
they age, elderly substance abusers would be gravely ill.
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Surprisingly, there have been very few published reports in
which this has been examined. This could be related to a
number of factors: first, reluctance of elderly patients to
participate in research studies, particularly when deeply
personal questions are asked (Buckwalter, 2009; Melberg &
Humphreys, 2010; Papaleontiou et al., 2010; Tourangeau &
Smith, 1996); second, lack of interest by researchers who
believe that substance abuse is only a problem of the young; or,
third, the inability to recruit substance-abusing older people
since they are so few in numbers because of “burnout” or the
severity of their comorbidity. No matter the reason, it remains
clear that studies of abuse in older people remain greatly
limited (Braden et al., 2010; Canfield et al., 2010; Dasgupta,
Mandl, & Brownstein, 2009; Paulozzi & Annest, 2007;
Paulozzi, Ballesteros, & Stevens, 2006; Regier et al., 1990;
Substance Abuse and Mental Health Services Administration
Office of Applied Studies, 2010).
In an effort to study this “underserved” population, we
recruited 2,573 patients, ranging in age from 18 to 75 years,
entering drug treatment programs around the country whose
primary drug was prescription opioid. Each of them
completed an anonymous self-administered survey that
covered a number of retrospective questions related to their
history of use and abuse of opioids, current drug abuse
problems, comorbid physical and psychiatric issues, and
general physical/mental health.
2. Methods and methods
2.1. Survey of Key Informants' Patients
The term key informants has been used for decades in
sociological research and, in terms of our research, is
defined as individuals who are well aware of drug abuse
issues and patterns in their catchment area; they include
researchers, ethnographers, and treatment specialists. In the
current studies, all of the key informants were treatment
center directors or their designees, who had daily contact
with large numbers of patients who met Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition
(DSM-IV) criteria for abuse/dependence on opioids. This
ongoing nationwide survey, termed the Survey of Key
Informants' Patients (SKIP), is a key element of the
postmarketing surveillance system: The Researched Abuse,
Diversion and Addiction-Related Surveillance System
(Cicero et al., 2007; Dart, 2009). Briefly, SKIP consists of
more than 100 mostly privately funded treatment centers,
balanced geographically (Cicero et al., 2007; Cicero,
Inciardi, & Muñoz, 2005; Cicero, Surratt, & Inciardi,
2007), with a good representation of large urban, suburban,
and rural treatment centers. Each of the treatment centers
was asked to recruit patients/clients who had a diagnosis of
opioid analgesic abuse or dependence using DSM-IV
(American Psychiatric Association, 1994) diagnostic criteria
and were just entering treatment (Cicero, Lynskey, Todorov,
Inciardi, & Surratt, 2008).
2.2. Subject recruitment
Inclusion criteria for this study were very broad: first,
subjects had to be 18 years or older (Institutional Review
Board [IRB] requirement); second, they had to meet DSM-IV
criteria for substance abuse whose primary drug was a
prescription opioid (i.e., not heroin); and, third, they used
prescription opioid drugs to get high at least once in the past
30 days prior to treatment. Overall, 85% of the patients
approached by the treatment counselors completed and
submitted surveys. The patients were asked to complete a
detailed, self-administered survey instrument, covering de-
mographics, licit and illicit patterns of drug use, diagnostic
criteria for alcohol and opioid abuse or dependence using last
30 day use (DSM-IV criteria), the Fagerström test for nicotine
dependence (Fagerstrom, 1978), general health status using
the SF-36v2 Health Survey (Hawthorne, Osborne, Taylor, &
Sansoni, 2007; Ware, Kosinski, & Dewey, 2001), and
whether they were currently being treated for a psychiatric
condition (Edlund et al., 2010).
2.3. SF-36 V2 health survey
With the release of SF-36v2, norms were calculated using
data from the 1998 National Survey of Functional Health
Status, and norm-based scoring algorithms were introduced
(Hawthorne et al., 2007; Ware et al., 2001). Using this
model, a T score of 50 (SD = 10) represents the average
health status of all adults in this country. A score greater than
50 indicates better than normal health, whereas a score less
than 50 represents poorer health. To control for the normal
age- and gender-related differences in physical and mental
health (e.g., presumably younger men and women would
have T scores greater than 50—better physical health than
the population as a whole), the SF-36v2 also calculates
composite population scores for all men and women by age
compared with the entire population. Thus, using age- and
gender-appropriate composite scores, the impact of opioid
abuse on the general physical and mental health status of
men and women entering treatment can easily be assessed.
2.4. Measures
Other than the customary demographics (age, gender,
ethnicity, employment status, and income), we obtained the
composite physical and mental health scores from the well-
validated SF-36v2, self-reported frequencies of psychiatric
disorders that required treatment, pain scored from none to
moderate severe, alcohol and nicotine dependence, and the
means used to divert opioid medications from the normal
medical supply chain.
2.5. Patient/subject confidentiality
Completed survey instruments were identified solely by a
unique case number and were sent directly to theWashington
88 T.J. Cicero et al. / Journal of Substance Abuse Treatment 42 (2012) 87–94
University School of Medicine. The treatment specialists did
not see the detailed responses of their patients/clients. The
protocol was approved by the Washington University IRB.
2.6. Data analyses
Data were analyzed using Predictive Analytics Software
(formerly SPSS) version 18. Bivariate logistic regression
models were developed to predict the influence of age and
gender on demographics, diversion methods used to obtain
prescription opioids, physical and mental health status,
alcoholism, and nicotine dependence. The significance level
was set at p b .01 for all comparisons.
3. Results
3.1. Demographics
As shown in Fig. 1, the frequency distribution of all 2,573
patients by age was an inverted U, bell-shaped curve with the
peak at 25–34 years of age. After that, there was a sharp
decline such that just 5% of the total population was older than
55 years. Given the low numbers of people older than 55 years
(n = 128), in subsequent analyses, we pooled data from those
45 years or older into a single category (n = 476). The sample
was predominately White (N80%). There were no gender- or
age-related differences observed in ethnicity nor were there
any ethnic differences observed on any dependent variable.
Approximately equal numbers of males and females were
present in each age group.Most were unemployed (N55%), but
income levels for those who were employed were comparable
to published rates for the general population.
3.2. Physical and mental health comorbidity
Fig. 2 shows the SF-36v2 physical and mental health
composite scores (mean, 95% confidence interval [CI]) in
opioid-abusing patients entering treatment compared with
age- and gender-appropriate population norms. As they
aged, both men and women entering treatment had
increasingly poorer physical health composite scores than
controls. However, the SF-36v2 mental health composite
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Fig. 1. Percentage of the total population (N = 2,573) falling into the age
brackets shown. The numbers in each age group are shown in italics on the
y axis.
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Fig. 2. Mean (95% confidence limits) composite physical and mental health scores for males and females on the SF-36V2 health survey. Age-adjusted population
norms, derived from large population studies carried out in validating the SF-36v2 instrument, for each age group are also shown.
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scores, at close to 2 standard deviations from the norm,
reflect even worse psychiatric health in aging males and
particularly females who misuse opioids. Consistent with the
global health analyses provided by the SF-36v2 composite
scores, Fig. 3 breaks out several aspects of the many physical
and mental health problems found in individuals with a
primary diagnosis of substance abuse. Table 1 shows the
odds ratios (ORs) for gender, and Table 2 shows the OR for
age on all dependent variables. Moderate to very severe
nonwithdrawal bodily pain, which interfered with work and
social activities, was a prominent feature in those in the 18–
24 age range, but this grew significantly with age such that
the odds of those individuals older than 45 years having
moderate to severe pain were two times greater than all other
age groups (OR = 2.12, p b .001). It is also apparent that the
incidence of self-reported psychiatric disorders that required
treatment was very high relative to published population
norms in all ages, but the incidence grew with age: the odds
of patients older than 45 years having a psychiatric disorder
were significantly greater (OR = 1.601, p b .001) than
younger patients. Overall, the odds of women having
psychiatric disorders were much greater than in males
(Table 1; OR = 2.11, p b .001). Fig. 3 also shows that there
was considerable comorbid alcoholism and nicotine depen-
dence in the treatment population. Rates of alcoholism were
high in the youngest cohort of opioid-abusing patients but
grew significantly with age: males and females older than
45 years had greater odds of alcoholism than younger
patients (OR = 2.33, p b .001). Nicotine dependence (i.e.,
smoking cigarettes) was also pervasive (Fig. 3). There were
no clear gender differences in either rates of alcoholism or
nicotine dependence.
3.3. Main source of primary drug
Fig. 4 shows age-related differences in the manner of
diversion used to obtain prescription opioids. Dealers were
used as a source of drugs by more than 70% of those 34 years
or younger but showed an age-related decline such that the
odds of individuals older than 45 years using a dealer were
considerably lower than younger ages (Table 2; OR = 0.37,
p b .001). The odds of men using dealers were greater than
females regardless of age (Table 1; OR = 1.380, p b .001). In
a seemingly compensatory fashion, the use of a doctor's
prescription as a source of drug showed precisely the
opposite age-related pattern: very few men and women in the
18- to 24-year-old group used a legitimate medical channel
to obtain drugs (Fig. 4), but this grew as a function of age
such that males (OR = 2.31, p b .001) and females (OR =
2.15, p b .001) older than 45 years had much higher odds of
using a doctor than younger men or women. Sharing was
more common in women than men (Table 1; OR = 1.37, p b
.001) but showed an age-related nonsignificant decrease as a
source of drugs in both genders. Theft or other illegal activity
to obtain drugs was endorsed by relatively small numbers of
young men and women, but the odds of women engaging in
theft were greater than in men (Table 1; OR = 1.34, p b .008)
at all ages.
4. Discussion
Prescription opioid abuse in this country has become
endemic over the past 15 years, which many believe was
given momentum by two significant events: first, the release
A B
C D
Fig. 3. Mean percentage of those in each age group who reported moderate to very severe pain (panel A) and psychiatric disorders (panel B) and met criteria for
alcoholism (panel C) or nicotine dependence (panel D).
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and subsequent diversion of a sustained release preparation
of oxycodone—OxyContin—which was falsely assumed by
the company and the Food and Drug Administration to have
low abuse potential (Cicero et al., 2005, 2008; General
Accounting Office, U.S., 2003; Grant et al., 2004;
Manchikanti et al., 2010; Schulden et al., 2009; Sproule,
Brands, Li, & Catz-Biro, 2009), and, second, the Joint
Commission on Accreditation of Healthcare Organizations'
report that named pain as the fifth vital sign and
recommended that opioids be used much more (Manchikanti
& Singh, 2008; Okie, 2010). This advice was obviously well
received: The use of opioids surged after this highly
publicized report, which inevitably resulted in some
diversion for nontherapeutic purposes (Cicero et al., 2007).
Aside from the debate on enabling factors, there is little
doubt that prescription opioid abuse now dwarfs heroin
abuse and, at least some other illegal drug use, as a public
health problem in this country.
Our data show that moderate to severe non-withdrawal-
related bodily pain—that greatly limited social contacts and
work—was common in most of those entering treatment:
45% of those 18–24 years old reported moderate to severe
pain. However, the incidence of this intense pain grew to
well over 70% in individuals 45 years or older. The mental
health status of men and, particularly, women entering
treatment was even worse. Depression, anxiety, and poly-
substance abuse (alcoholism and nicotine dependence) were
already prevalent in our youngest sample at rates far greater
than population norms, but mental health deteriorated
rapidly, with the result that most of those older than 45
years were with psychiatric disorders. Although these
observations are consistent with prior reports of comorbidity
Table 1
Bivariate logistic regressions evaluating the influence of gender on the dependent variables shown
Variable
Females (n = 1,333)
OR (95% CI)
Males (n = 1,240)
OR (95% CI) p
Source of primary opioid
Dealer 0.73 (0.62–0.85) 1.38 (1.18–1.62) b.001
Medical 1.28 (1.10–1.50) 0.78 (0.67–0.91) .002
Shared 1.37 (1.17–1.60) 0.73 (0.62–0.85) b.001
Stolen 1.34 (1.08–1.67) 0.75 (0.60–0.92) .008
Psychiatric disorder
Any 2.11 (1.80–2.47) 0.47 (0.40–0.56) b.001
Anxiety 1.51 (1.21–1.89) 0.66 (0.53–0.83) b.001
Bipolar 1.57 (1.23–2.10) 0.64 (0.50–0.82) b.001
Depression 1.90 (1.47–2.44) 0.53 (0.41–0.68) b.001
Other 0.91 (0.71–1.17) 1.10 (0.85–1.41) .47
Physical health
Moderate to severe pain in last 7 days 1.09 (0.93–1.28) 0.91 (0.78–1.07) .26
Substance use
Alcohol dependence 0.86 (0.73–1.03) 1.16 (0.98–1.38) .09
Nicotine dependence 1.24 (1.01–1.51) 0.81 (0.66–0.99) .04
Note. Numbers in bold are statistically significant (a priori set at p b .01).
Table 2
Bivariate logistic regressions evaluating the influence of age in the dependent variables shown
Variable
18–24 (n = 494)
OR (95% CI) p
25–34 (n = 998)
OR (95% CI) p
35–44 (n = 605)
OR (95% CI) p
45+ (n = 476)
OR (95% CI) p
Source of primary opioid
Dealer 2.05 (1.65–2.54) b.001 1.53 (1.30–1.81) b.001 0.75 (0.63–0.91) .003 0.37 (0.30–0.45) b.001
Medical 0.41 (0.33–0.50) b.001 0.89 (0.76–1.05) .16 1.28 (1.06–1.53) .009 2.20 (1.79–2.70) b.001
Shared 1.23 (1.01–1.49) .04 1.11 (0.95–1.30) .20 0.86 (0.71–1.03) .10 0.83 (0.68–1.02) .07
Stolen 1.40 (1.09–1.81) .009 1.19 (0.96–1.48) .11 0.74 (0.56–0.96) .03 0.72 (0.53–0.97) .03
Psychiatric disorder
Any 0.68 (0.55–0.83) b.001 0.84 (0.72–0.99) .03 1.20 (1.00–1.45) .05 1.60 (1.30–1.97) b.001
Anxiety 0.64 (0.48–0.85) .002 1.45 (1.15–1.83) .002 0.97 (0.75–1.25) .82 0.91 (0.70–1.19) .51
Bipolar 0.82 (0.59–1.14) .23 1.00 (0.79–1.28) .10 1.11 (0.85–1.44) .46 1.05 (0.79–1.39) .76
Depression 0.52 (0.38–0.71) b.001 1.15 (0.89–1.50) .29 1.17 (0.87–1.57) .30 1.25 (0.91–1.71) .17
Other 1.80 (1.32–2.45) b.001 1.15 (0.90–1.49) .27 0.82 (0.61–1.10) .19 0.58 (0.41–0.80) .001
Physical health
Moderate to severe pain in last 7 days 0.53 (0.44–0.65) b.001 0.78 (0.67–0.92) .003 1.34 (1.11–1.62) .002 2.12 (1.70–2.64) b.001
Substance use
Alcohol dependence 0.58 (0.46–0.73) b.001 0.65 (0.54–0.78) b.001 1.34 (1.10–1.64) .004 2.33 (1.86–2.91) b.001
Nicotine dependence 0.57 (0.44–0.72) b.001 1.01 (0.83–1.24) .89 1.35 (1.06–1.73) .02 1.30 (0.99–1.71) .06
Note. Numbers in bold are statistically significant (a priori set at p b .01).
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in substance misusers (Cicero et al., 2009; McCabe et al.,
2008; Skurtveit et al., 2010; Sullivan et al., 2005; Sullivan
et al., 2006), the age and gender relatedness of these effects
has not to our knowledge been fully appreciated until now.
What seems clear is that treatment, prevention, and
intervention programs would seem to be destined to fail if
age and gender are not carefully considered in tailoring these
efforts to specific populations.
Given the poor health we observed, it seems reasonable to
postulate that disability, serious medical issues, and/or other
factors (e.g., economic, risk aversion in seeking drugs—see
below) would lead to the forced cessation of drug use in
long-term substance abusers (i.e., “burnout”). If this is true,
then one might expect, as we found, an age-related drop in
drug-seeking behavior and in those seeking drug abuse
treatment. However, it seems far more likely that, as they
age, treatment for the medical complications associated with
substance abuse (e.g., cognitive impairments, psychiatric
disorders, organ failure, and so forth) may become much
more clinically relevant than substance abuse treatment per
se. Thus, a drop in the number of elderly people seeking drug
treatment should not necessarily be assumed to indicate that
the disease has run its course but that aging addicts end up in
medical specialty treatment programs rather than drug
treatment centers. In this connection, it should be noted
that the comorbid conditions often associated with or caused
by substance abuse are generally covered by insurance
companies, whereas the public and private health insurance
industry has become increasingly reluctant to cover
substance abuse treatment per se in nearly any form. Thus,
it could be that it is more economical and practical for
patients and hospitals to treat the medical complications
associated with abuse but not the underlying problem itself
as the population of abusers age. We know of no studies in
which this hypothesis has been systematically addressed.
As mentioned above, our study was not longitudinal, and
it is therefore possible that the huge surge of youthful opioid-
abusing patients who began using drugs in the 1993–2010
time frame have not yet reached the age of 40. If this
hypothesis is correct, the number of elderly people seeking
treatment should continue to rise over the next 5–10 years,
which will represent a huge burden on drug treatment centers
that are generally ill equipped to handle the plethora of
serious psychiatric and physical ailments found in aging
opioid-abusing patients.
As discussed above, we found in agreement with an
earlier study that age and gender influenced the modes of
diversion used to siphon drugs from medically appropriate
channels to the illicit marketplace (Cicero, Ellis, Paradis, &
Ortbal, 2010; Cicero, Kurtz, et al., 2010). At any age, women
were much less likely to use a dealer than men, and, as they
aged, both men and women were also more inclined to use
medical channels as their primary source of drugs rather than
dealers whose use predominates in younger men. These data
could reflect the fact that women are much more risk averse
than men and that, as they age, both men and women's risk
aversion makes doctors a much safer bet than dealers.
However, other possibilities exist. Although it is certainly
less risky to use a doctor than a dealer, the enhanced use of
medical channels could be due to the fact that it is far easier
for elderly patients with pain to get a doctor's prescription for
an analgesic than it would be for younger males and females
to do so. In addition, it is also possible that it is much more
economical, provided private- or government-funded insur-
ance is available, to deal with a doctor rather than a dealer.
Thus, at least some of the age-related inversion between
dealers and doctors may be due to ease of access and
economic concerns. Whichever explanation is correct,
family practitioners, who prescribe the bulk of all opioids
in the United States, should be just as cautious about
potential opioid misuse in elderly persons as they might be
for younger patients.
The largest confound in our studies is whether the
comorbidity we observed is caused by the lengthy
punishment inflicted by heavy substance abuse or if
substance abuse is merely a symptom of a much larger
constellation of psychiatric and physical problems, which
grow worse with age, in a highly vulnerable subgroup of the
general population. This confound probably can never be
clearly resolved, but there is ample evidence (Manchikanti
et al., 2010; McCabe et al., 2008; Rogers & Copley, 2009;
Schulden et al., 2009; Skurtveit et al., 2010), including the
present data, that adolescents and young adults who misuse
opioids and other drugs have clear psychiatric and substance
abuse (e.g., alcoholism) issues long before their misuse of
opioids begins. This suggests that substance abuse is merely
one symptom of a much larger constellation of problems and
is not the causal factor in the poor physical and mental health
we observed. However, it is difficult not to conclude that the
deterioration in health over time is due, in some appreciable
measure, to poor lifestyle choices including excessive
opioid, alcohol, and other drug abuse issues.
There are limitations in our study. All of our surveys were
self-administered, and thus, they have most of the problems
Fig. 4. The percentage of those in each age bracket who used the modes of
diversion shown. ORs for the influence of gender and age on the disorders
shown are contained in Tables 1 and 2, respectively.
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associated with these methods, particularly the inability to
follow up answers with additional questions to clarify any
ambiguities and truthfulness (Aquilino & LoSciuto, 1990;
Aquilino, 1994; Hochstim, 1967). A second limitation is that
our study population was confined to those entering
treatment in many cases for the fourth or fifth time. Thus,
this population, and their profound problems with drugs and
other psychopathology, may be very different than less-ill,
“recreational” drug users. Although all of these possibilities
need to be kept in mind in interpreting our results, the
anonymity provided by the self-administered questionnaire
has been shown to produce much more candid and valid
drug-related responses than interviewer- elicited information
regarding substance abuse issues. Moreover, in a recently
published study, it was found that the results of self-
administered surveys and face-to-face interviews regarding
sources of diversion were almost perfectly correlated
(Cicero, Kurtz, et al., 2010).
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